logo
Select company
Select metric
$ 181KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
40
Sector
70
Industry
83
History
91
$ 8.17Close
$ 6.38 - $ 27.03 52-Week Range
Ticker Information

Ticker

BCYC

Company Name

BICYCLE THERAPEUTICS PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BICYCLE THERAPEUTICS PLC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BCYC - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 181K
3/31/2025$ 549.79M
12/31/2024$ 551.65M
9/30/2024$ 551.8M
6/30/2024$ 786.49M
3/31/2024$ 249.18M
12/31/2023$ 250.03M
9/30/2023$ 255.53M
6/30/2023$ 21.06M
3/31/2023$ 8.96M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BICYCLE THERAPEUTICS PLC's latest trailing twelve months (TTM) CF - Equity stands at $ 46.59M.
  • Over the past 5 years, BICYCLE THERAPEUTICS PLC's average CF - Equity has been $ 232.5M.
  • The median CF - Equity for BICYCLE THERAPEUTICS PLC during this period was $ 211.61M
  • BICYCLE THERAPEUTICS PLC reached its highest CF - Equity over the past 5 years at $ 786.49M.
  • The lowest CF - Equity recorded by BICYCLE THERAPEUTICS PLC in the same timeframe $ 181K

BICYCLE THERAPEUTICS PLC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
ALMS : ALUMIS INC $ 234.12MVIR : VIR BIOTECHNOLOGY INC $ 4.33MABUS : ARBUTUS BIOPHARMA CORP $ 6.43MZBIO : ZENAS BIOPHARMA INC $ 237.65MCAPR : CAPRICOR THERAPEUTICS INC $ 148.48MAUTL : AUTOLUS THERAPEUTICS PLC $ 192KQURE : UNIQURE NV $ 82.79MRLAY : RELAY THERAPEUTICS INC $ 220.34MTNGX : TANGO THERAPEUTICS INC $ 3.95MFHTX : FOGHORN THERAPEUTICS INC $ 1.45M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

BCYC - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 181K

Minimum

Jun 30, 2025

$ 786.49M

Maximum

Jun 30, 2024

$ 232.5M

Average

$ 211.61M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 124.49K
median$ 0
std$ 17.66M